000 01500 a2200445 4500
005 20250516011659.0
264 0 _c20110325
008 201103s 0 0 eng d
022 _a1543-8392
024 7 _a10.1021/mp100210g
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSlütter, Bram
245 0 0 _aAntigen-adjuvant nanoconjugates for nasal vaccination: an improvement over the use of nanoparticles?
_h[electronic resource]
260 _bMolecular pharmaceutics
_cDec 2010
300 _a2207-15 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdjuvants, Immunologic
_xadministration & dosage
650 0 4 _aAdministration, Intranasal
650 0 4 _aAnimals
650 0 4 _aAntigens
_xadministration & dosage
650 0 4 _aCells, Cultured
650 0 4 _aChitosan
_xadministration & dosage
650 0 4 _aDrug Delivery Systems
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aNanoparticles
_xadministration & dosage
650 0 4 _aOvalbumin
_xadministration & dosage
650 0 4 _aVaccination
650 0 4 _aVaccines, Conjugate
_xadministration & dosage
700 1 _aBal, Suzanne M
700 1 _aQue, Ivo
700 1 _aKaijzel, Eric
700 1 _aLöwik, Clemens
700 1 _aBouwstra, Joke
700 1 _aJiskoot, Wim
773 0 _tMolecular pharmaceutics
_gvol. 7
_gno. 6
_gp. 2207-15
856 4 0 _uhttps://doi.org/10.1021/mp100210g
_zAvailable from publisher's website
999 _c20343035
_d20343035